Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
No major trials have tested GLP-1s in healthy people with a normal or low BMI, so its unclear how much weight such people might lose on the drug
Virologic failure with a raltegravir-containing antiretroviral regimen and concomitant calcium administration
A 2025 study published in Endocrine Practice confirmed that patients switching from GLP-1 drugs directly to tirzepatide 5 mg showed improvements in blood sugar control within 12 weeks without unusual safety concerns
By mimicking the actions of naturally occurring hormones, it enhances insulin secretion when glucose levels are elevated, thereby controlling blood sugar and reducing hunger
Funding This study was supported by grants from the Scientific Research Foundation of the Ministry of Education of China (Grant No.2021JH019) and Scientific Research Foundation of Postdoctoral Department of Heilongjiang Province (Grant No.LBH-Q21025)
Discourse Soc
US$ 27.80
US$ 21.88
US$ 24.93
US$ 22.10
US$ 21.15
